Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5645591 | Clinical Skin Cancer | 2016 | 7 Pages |
Abstract
PD-1 blocking agents may provide clinically meaningful and palliative therapy for patients with aggressive cSCC who are not surgical candidates.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Georgia M. Beasley, James Kurtz, Jeff Vandeusen, J. Harrison Howard, Alicia Terando, Doreen Agnese, David Liebner, Joanne Jeter, Thomas Olencki,